Leishmania donovani Nucleoside Hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection

Leishmania donovani Nucleoside Hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection

Nucleoside hydrolases of the Leishmania genus are vital enzymes for the replication of the DNA and conserved phylogenetic markers of the parasites. Leishmania donovani Nucleoside hydrolase (NH36) induced a main CD4+ T cell driven protective response against Leishmania chagasi infection in mice which...

Full description

Bibliographic Details
Main Authors:	Dirlei eNico, Daniele Crespo Gomes, Iam ePalatnik-de-Sousa, Alexandre eMorrot, Marcos ePalatnik, Clarisa B. Palatnik-De-Sousa
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-06-01
Series:	Frontiers in Immunology
Subjects:	Visceral leishmaniasis cutaneous leishmaniasis diffuse cutaneous leishmaniasis cross-immunotherapy Nucleoside hydrolases recombinant vaccines
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00273/full

Similar Items

Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+-epitopes of Leishmania donovani Nucleoside Hydrolase terminal domains
by: Dirlei eNico, et al.
Published: (2014-05-01)

Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines
by: Clarisa Beatriz Palatnik-de-Sousa, et al.
Published: (2019-04-01)

F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis
by: Eugenia Carrillo, et al.
Published: (2017-07-01)

The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice
by: Marcus Vinícius Alves-Silva, et al.
Published: (2019-04-01)

O uso da associação azitromicina e N-metil glucamina no tratamento da leishmaniose cutânea causada por Leishmania (Leishmania) amazonensis em camundongos C57BL6 The use of azythromycin and N-methyl glucamine for the treatment of cutaneous Leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL6 mice
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2009-04-01)

Toward an approach for cutaneous leishmania treatment
by: Mohammed Wael Daboul
Published: (2013-01-01)

Atividade leishmanicida de extrato hidroalcoólico de própolis brasileira em Leishmania amazonensis
by: Suelen Santos da Silva, et al.
Published: (2015-12-01)

Estudo comparativo entre miltefosina oral e antimoniato de N-metil glucamina parenteral no tratamento da leishmaniose experimental causada por Leishmania (Leishmania) amazonensis Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis
by: Arnoldo Velloso da Costa Filho, et al.
Published: (2008-08-01)

Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi
by: M. P. Oliveira Neto, et al.
Published: (1986-09-01)

Interleukin- 2 production during murine infection by Leishmania mexicana amazonensis
by: Manoel Barral-Netto, et al.
Published: (1986-03-01)

In vitro activity of the hydroethanolic extract and biflavonoids isolated from Selaginella sellowii on Leishmania (Leishmania) amazonensis
by: Yasmin Silva Rizk, et al.
Published: (2014-12-01)

The role of complement in the early phase of Leishmania (Leishmania) amazonensis infection in BALB/c mice
by: M.D. Laurenti, et al.
Published: (2004-03-01)

Inefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensis
by: R. N. R. Sampaio, et al.
Published: (2007-01-01)

The first documentation of the immune response to cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka.
by: D. Atapattu, et al.
Published: (2017-10-01)

American tegumentary leishmaniasis: epidemiological and molecular characterization of prevalent Leishmania species in the State of Tocantins, Brazil, 2011-2015
by: Carina Scolari Gosch, et al.
Published: (2017-12-01)

Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA
by: Marcos de Almeida, et al.
Published: (2021-06-01)

Cell migration induced by Leishmania (Leishmania) amazonensis, Leishmania (Leishmania) major and Leishmania (Viannia) braziliensis into the peritoneal cavity of BALB/c mice
by: DT Wakimoto, et al.
Published: (2010-01-01)

Cellular Markers of Active Disease and Cure in Different Forms of Leishmania infantum-Induced Disease
by: Laura Botana, et al.
Published: (2018-11-01)

Leishmania martiniquensis is a New Causative Agent for Cutaneous and Visceral Leishmaniasis in Humans
by: S. B. Chuelov, et al.
Published: (2018-12-01)

Effect of Direct Electricity Current on Viability of Leishmania (L) tropica Promastigotes: an in vitro Study
by: M Malek, et al.
Published: (2016-01-01)

Licochalcone a Exhibits Leishmanicidal Activity in vitro and in Experimental Model of Leishmania (Leishmania) Infantum
by: Julia M. Souza, et al.
Published: (2020-12-01)

Leishmania donovani and Cutaneous Leishmaniasis, Sri Lanka
by: H. V. Yamuna D. Siriwardana, et al.
Published: (2007-03-01)

A Case Report of a Rare Leishmaniasis Patient with More than 29 Acute lesions
by: Mostafavi R, et al.
Published: (2011-06-01)

A Case Report of a Rare Leishmaniasis Patient with More than 29 Acute lesions
by: A Saghafipour, et al.
Published: (2011-06-01)

Leishmania tropica infection of the ear treated with photodynamic therapy
by: Harry Goldin, MD, et al.
Published: (2020-06-01)

Vaccines for canine leishmaniasis
by: Clarisa B. Palatnik-De-Sousa
Published: (2012-04-01)

Leishmania life cycle images in the cutaneous cytologic smear of an immunocompetent patient
by: Zappacosta Roberta, et al.
Published: (2010-01-01)

Isolation and Molecular Identification of Leishmania spp. Agents in Patients with Cutaneous Leishmaniasis in Yazd Province, Endemic Region of Central Iran
by: Gilda ESLAMI, et al.
Published: (2020-05-01)

In Vitro Effect of Methanolic Extract of Quercus infectoria Galls on Promastigotes and Amastigotes of Leishmania major (MRHO/IR/75/ER)
by: Asghar Farghi Yamchi, et al.
Published: (2018-09-01)

Identificación de especies de Leishmania en pacientes y flebotominos en áreas de transmisión en una región del Perú Identification of Leishmania species in patients and phlebotomines in transmission areas in a region of Perú
by: Ofelia Córdova, et al.
Published: (2011-09-01)

Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
by: Michal Solomon, et al.
Published: (2019-04-01)

Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report
by: Jacinto Convit, et al.
Published: (2004-02-01)

Cytotoxicity and anti-Leishmania amazonensis activity of Citrus sinensis leaf extracts
by: Andreza R. Garcia, et al.
Published: (2017-01-01)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
by: Ma. Florencia Peralta, et al.
Published: (2021-05-01)

Comparison of the specificity of PCR and the histopathological detection of leishmania for the diagnosis of American cutaneous leishmaniasis
by: A.C.R. Medeiros, et al.
Published: (2002-04-01)

The Effects of Prednisolone and Mometasone on Wound Healing Caused by Leishmania Major in Balb/c Mice
by: Ghazaleh Mahabadi, et al.
Published: (2020-08-01)

Experimental infection of Lutzomyia longipalpis fed on a patient with cutaneous leishmaniasis due to Leishmania mexicana amazonensis
by: Leonidas M. Deane, et al.
Published: (1986-03-01)

Bionomic aspects of Lutzomyia evansi and Lutzomyia longipalpis, proven vectors of Leishmania infantum in an endemic area of non-ulcerative cutaneous leishmaniasis in Honduras
by: Ángel Mejía, et al.
Published: (2018-01-01)

Disseminated cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in human immunodeficiency virus (HIV)-infected patients: A report of two cases
by: Camila F Araujo, et al.
Published: (2021-01-01)

Polymerase chain reaction detection of LeishmaniaDNA in skin biopsy samples in Sri Lanka where the causative agent of cutaneous leishmaniasis is Leishmania donovani
by: Shalindra Ranasinghe, et al.
Published: (2015-12-01)